BioSpace News Archive

Drug Development

Compass, Astrazeneca Move Forward in Biliary Tract Cancer Treatments

Compass and AstraZeneca have both provided updates to their clinical therapeutic programs focused on biliary tract cancers.

May 4, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

Phathom Wins Approvals Against Antibiotic Resistance in H. pylori

The FDA has approved two of Phathom Pharmaceuticals’ products for bacterial illnesses in adults: Voquezna Triple Pak and Voquezna Dual Pak.

May 4, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

BMS and Merck Buy Big Into Amphista’s Protein Degradation Platform

Amphista Therapeutics forged two significant protein degradation partnerships with big pharma. Wednesday, the U.K.-based company announced partnerships with both Bristol Myers Squibb and Merck KGaA that have a combined value of more than $2 billion.

May 4, 2022
·
3 min read
·
Alex Keown
Drug Development

Athira Investor Calls For Former GSK Exec to Take Reigns

Athira investor Richard Kayne appears to be making a strong push for Dr. Ronald Krall, former chief medical officer of GlaxoSmithKline, to run the company, despite protests from Athira’s board.

May 4, 2022
·
3 min read
·
Mark Terry
Drug Development

Context Therapeutics is Targeting Progesterone to Outsmart Tumors in Women’s Cancers

Context Therapeutics’ lead candidate ONA-XR prevents interaction between progesterone and its receptor, downregulates cancer stem cell mobilization and blocks immune evasion.

May 4, 2022
·
5 min read
·
Gail Dutton
Drug Development

Global Roundup: FDA Hits Junshi, HUTCHMED with Complete Response Letters

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

May 4, 2022
·
7 min read
·
Alex Keown
Business

Awakn’s Anthony Tennyson on Providing Hope for Those Suffering from Addiction

Awakn researches and develops drug-assisted psychotherapy treatments, focusing on psychedelic drugs to treat addiction.

May 4, 2022
·
6 min read
·
Gail Dutton
Business

Jazz Adds Narcolepsy Pact with Sumitomo, Sees Clear Ahead to Vision 2025

Jazz’s Q1 included a key licensing deal with Werewolf Therapeutics and another announced Wednesday with Japan’s Sumitomo Pharma Co. for a narcolepsy treatment.

May 4, 2022
·
3 min read
·
Alex Keown
Drug Development

Following Q1 Assessment, Allogene Remains Focused on CAR-T Therapy

After the market closed on Wednesday, Allogene reported its first-quarter financial results, along with updates to its research programs. The report marked Allogene’s fourth anniversary.

May 4, 2022
·
2 min read
·
Hayley Shasteen
Endoscopy Irrigation Pumps Market: North America is Projected to Hold a Prominent Share of the Global Market

Albany NY, United States: Endoscopy is a minimally invasive procedure performed to examine internal cavities or lumen in the body such as the gastrointestinal track, pericardial cavity, space around joints, etc.

May 4, 2022
·
5 min read